510(k) · Cleared
ClearedDerma-Gide
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Geistlich Pharma AG · KGN Wound Dressing With Animal-Derived Material (S)
Cleared on Mar 19, 2026 as substantially equivalent to K182838 (Geistlich Pharma AG, 2018) and 1 other predicate after a 30-day review. Its family tree reaches back 4 generations to 2006.
- Decided
- Mar 19, 2026
- Review
- 30 days
- Class
- Class U
- Product code
- KGN
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 4 generations to K061711 (2006). No later device cites it as a predicate yet.
- Root · 4 generations backK061711 Oasis Wound MatrixCook Biotech, Inc. · 2006
- 3 generations backK140510 Miromatrix Wound MatrixMiromatrix Medical, Inc. · 2014
- 2 generations backK171842 Geistlich Wound MatrixGeistlich Pharma AG · 2017
- 1 generation backK182838 Geistlich Derma-GideGeistlich Pharma AG · 2018
- This deviceK260532 Derma-GideGeistlich Pharma AG · 2026
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −4 | K061711 | Oasis Wound Matrix | Cook Biotech, Inc. | 2006 | — |
| −3 | K140510 | Miromatrix Wound Matrix | Miromatrix Medical, Inc. | 2014 | — |
| −2 | K171842 | Geistlich Wound Matrix | Geistlich Pharma AG | 2017 | — |
| −1 | K182838 | Geistlich Derma-Gide | Geistlich Pharma AG | 2018 | — |
| 0 (this device) | K260532 | Derma-Gide | Geistlich Pharma AG | 2026 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in KGN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new KGN device
- #1 K231325 Corplex P / Theracor P / Allacor Pscore 17.9 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K182838 | Geistlich Derma-GideSummary page 5…al equivalence is claimed to the following devices: Product Name 510(k) Applicant Geistlich Derma-Gide™ K182838 Geistlich Pharma AG Geistlich Wound Matrix K171842 Geistlich Pharma AG IV. Device Description… | 2018 |
| * | K171842 | Geistlich Wound MatrixSummary page 5…510(k) Applicant Geistlich Derma-Gide™ K182838 Geistlich Pharma AG Geistlich Wound Matrix K171842 Geistlich Pharma AG IV. Device Description Derma-Gide is a sterile, single-use only, acellular advanced wound care devi… | 2017 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 20 years and passes through 3 companies; a new generation was cleared every 7.4 years on median.
- None of the 4 ancestors has a recall.
How does its category compare?
All KGN devicesKGN Wound Dressing With Animal-Derived Material (S): FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.
FDA decisions per year · KGN
15so far in 2026, the most since 2007
2026 to Oct 25, outlined.
Median 510(k) review, days · KGN
162in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · KGN
3in 2018
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · KGN
15in 2025
MAUDE reports naming product code KGN, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 32 | 0 | 0 |
| 2008 | 6 | 87 | 0 | 1 |
| 2009 | 8 | 121 | 0 | 2 |
| 2010 | 4 | 175 | 0 | 3 |
| 2011 | 7 | 228 | 0 | 6 |
| 2012 | 8 | 123 | 0 | 4 |
| 2013 | 6 | 147 | 0 | 6 |
| 2014 | 5 | 188 | 0 | 12 |
| 2015 | 7 | 87 | 0 | 9 |
| 2016 | 4 | 164 | 0 | 6 |
| 2017 | 7 | 136 | 1 | 8 |
| 2018 | 6 | 148 | 3 | 15 |
| 2019 | 3 | 128 | 0 | 11 |
| 2020 | 5 | 279 | 0 | 17 |
| 2021 | 6 | 236 | 0 | 14 |
| 2022 | 12 | 246 | 0 | 13 |
| 2023 | 9 | 194 | 0 | 21 |
| 2024 | 13 | 83 | 0 | 15 |
| 2025 | 10 | 162 | 0 | 15 |
| 2026 | 15 | 174 | 0 | — |
What is it indicated for?
Derma-Gide is intended for the management of wounds including:
• partial and full thickness wounds
• pressure ulcers
• venous ulcers
• diabetic ulcers
• chronic vascular ulcers
• surgical wounds (donor sites/grafts, post Moh’s surgery, post laser surgery, podiatric, wound dehiscence)
• trauma skin wounds (abrasions, laceration, partial thickness second degree burns, skin tears)
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K260532 · printed Nov 5, 2026
Cite this page
510(k) Report. “K260532: Derma-Gide.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K260532
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026